RxDoctor Payments Data

Simon Garceau

Orthopaedic Surgery · New York, NYNPI 1962064378

Payments from drug & device makers

What this record shows

This record is dominated by education: $19,833 of the $20,167 with a category attached, or 98.3%. Smith+Nephew accounts for 98.3% of it on its own, with 3 other manufacturers making up the rest.

$20,167in general payments, 2019–2025

Across 8 payments — averaging $2520.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$20K
  • Stryker$223
  • Zimmer Biomet$94
  • Cumberland Pharmaceuticals, Inc.$16
$625,587in research payments, 2019–2025

Across 11 payments — averaging $56,872 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Next Science LLC$626K

What the payments were for

  • Food & beverage$3332%
  • Education$19,83398%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$20,167 in reported general payments places this provider in the 75th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →